论文部分内容阅读
目的:探讨尿液微量白蛋白(mAlb)和视黄醇结合蛋白(RBP)在糖尿病肾病患者中的诊断价值。方法:采用免疫透射比浊法检测糖尿病肾病患者尿液中的尿微量白蛋白(mAlb)和视黄醇结合蛋白(RBP),并在尿液分析仪上检测蛋白定性试验,以正常健康体检为对照组,进行对比分析。结果显示,糖尿病肾病患者中尿微量白蛋白(mAlb)、视黄醇结合蛋白(RBP)。结果:高于正常对照组;且尿蛋白阳性组高于阴性组,差异均有统计学意义(P<0.01)。结论:早期检测尿微量白蛋白和视黄醇结合蛋白,对糖尿病肾病诊断有着指导意义。
Objective: To investigate the diagnostic value of urine microalbumin (mAlb) and retinol binding protein (RBP) in patients with diabetic nephropathy. Methods: Urine microalbumin (mAlb) and retinol binding protein (RBP) in urine of patients with diabetic nephropathy were detected by immunoturbidimetry. Qualitative proteinuria test was performed on urine analyzer. Control group, comparative analysis. The results showed that patients with diabetic nephropathy urine microalbumin (mAlb), retinol binding protein (RBP). Results: Higher than the normal control group; and urine protein positive group was higher than the negative group, the difference was statistically significant (P <0.01). Conclusion: Early detection of urinary microalbumin and retinol binding protein may play a guiding role in the diagnosis of diabetic nephropathy.